CNBC Investing Club

We are adding to our position in this drug stock

More In CNBC Investing Club Newsletter

CNBC Investing ClubWe break down Morgan Stanley’s solid fourth-quarter earnings
CNBC Investing ClubInvesting Club: What Jim Cramer is watching Wednesday — Some buying opportunities developing
CNBC Investing ClubCramer's Investing Club: We're adding to one portfolio stock, watching another former name